Research reportProtein kinases A and C are involved in the mechanisms underlying consolidation of cocaine place conditioning
Introduction
Protein kinases appear to play an important role in various plastic phenomena such as long-term potentiation (LTP), kindling and learning. LTP, a stable form of synaptic plasticity widely studied as a cellular model of learning and memory, has been amply investigated with the aim of clarifying the neurochemical mechanisms involved in various phases of the phenomenon 26, 30. Evidence is accumulating that protein kinase C (PKC) activation is necessary to convert short-term potentiation to LTP suggesting that the kinase is involved in its induction and consolidation. Protein kinase A (PKA), on the other hand, seems to be involved in the expression of cAMP-inducible genes 2, 30in a late phase of LTP [28].
Addiction to drugs is considered to be the result of plastic changes in multiple neural circuits and progress is being made in understanding the mechanisms involved in sensitization and cue-dependent memories of drug use 4, 8, 9, 19, 20, 44. The conditioned place preference (CPP) model is commonly used for studying the reinforcing properties of drugs 3, 7, 42and the ability of cues associated with drugs of abuse to elicit place preference may have important implications for the study of drug `craving' and relapse 24, 33.
The CPP consists of an acquisition phase during which rats receive the drug in one distinctive environment, and a test or expression phase in which drug-free animals are tested for their preference for the environment previously paired with the drug. A recent study in our laboratory showed that dopaminergic D1 and glutamatergic NMDA receptors were involved in the establishment of cocaine CPP whereas AMPA/kainate receptors were important only for CPP expression [8]. Cocaine raises the extracellular concentrations of dopamine and glutamate in the nucleus accumbens 23, 35and after repeated treatment it raises the levels of adenylate cyclase and cAMP-dependent protein kinase activity in the nucleus accumbens [40]. Moreover, chronic cocaine causes sensitization to the motor stimulant properties and this effect is blocked by NMDA receptor antagonists 21, 22. An interesting interaction between dopamine D1 and NMDA receptors is also suggested by the finding that antagonists at these receptors block the induction of c-fos by cocaine in the rat brain 41, 45. Because the dopaminergic D1 receptors stimulate adenylate cyclase [23]and various glutamate receptors lead to activation of PKC 2, 32, 34, it is likely that PKA and PKC are involved in various phases of cocaine CPP.
While various studies have associated changes in PKA with adaptive phenomena consequent to chronic use of opioids (see Ref. [27]), there is little information on the role of these two kinases in cocaine-induced plastic phenomena. Chronic treatment with cocaine has been reported to activate PKA [40]and a recent study reported that administration of H7, a non-selective protein kinase inhibitor [17], into the ventral tegmental area blocked the development of sensitization to cocaine [37].
In the present study we evaluated the roles of PKA and PKC in the acquisition, consolidation and expression of cocaine CPP using H7, a non-selective inhibitor of protein kinases. Since H7 selectively reduced the consolidation of cocaine CPP, we administered immediately after each conditioning session two compounds having different selectivity in inhibiting PKA or PKC, H89 and chelerythrine 11, 16, to clarify which protein kinase mainly contributed to the effect of cocaine.
Section snippets
Animals
Male Sprague–Dawley CD-COBS rats (Charles River, Italy), weighing 225–250 g at the beginning of the experiment, were used. They were housed individually at constant room temperature (21±1°C) and relative humidity (60%) under a regular light/dark schedule (light 07.30–19.30 h) with food and water ad libitum. Animals were allowed to adapt to laboratory conditions for at least 1 week and were handled for 5 min per day during this adaptation period. Testing and training were conducted between 09.30
Results
Fig. 1 shows the effect of H7 on the cocaine-induced increase in locomotor activity. Administered i.c.v. 10 min before testing, H7 significantly modified the hyperlocomotion induced by 10 mg/kg cocaine (F2,49=2.8, P<0.05, two-way ANOVA). Post-hoc comparison indicated that 30 μg but not 10 μg reduced the number of photobeam interruptions (P<0.05 vs. control group, Tukey's test). Neither 30 nor 10 μg H7 modified the number of photobeam interruptions in the control group (P>0.05, Tukey's test).
In
Discussion
Considerable evidence suggests that PKC and PKA are part of the molecular cascade of events leading to memory consolidation 6, 14, 25, 28, 29, 34, 38, 39but their role in cue-dependent memories of drug use that may predispose to relapse is not clear. Since cues associated with drugs of abuse may elicit place preference, with important implications for the study of drug `craving' and relapse 24, 33, we examined the role of protein kinases in the acquisition, consolidation and expression of
Acknowledgements
The authors wish to thank Miss Francesca Valsecchi and Miss Dominique Morgan for their contribution to part of this study. Miss Dominique Morgan was on leave from the University of Wales, Department of Physiology, Cardiff, UK.
References (45)
Molecular enhancement of memory formation
Neuron
(1996)- et al.
Effects of dopaminergic and glutamatergic receptor antagonists on the acquisition and expression of cocaine conditioning place preference
Brain Res.
(1995) - et al.
Effects of dopaminergic and glutamatergic receptor antagonists on the establishment and expression of conditioned locomotion to cocaine in rats
Brain Res.
(1996) - et al.
Inhibition of forskolin-induced neurite out-growth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamyl-amino)ethyl]-5-isoquinolinesulfonamide (H89), of PC12D pheochromocytoma cells
J. Biol. Chem.
(1990) - et al.
Chelerythrine is a potent and specific inhibitor of protein kinase C
Biochem. Biophys. Res. Commun.
(1990) - et al.
Cocaine reinforcement and extracellular dopamine overflow in rat nucleus accumbens: an in vivo microdialysis study
Brain Res.
(1989) - et al.
DNQX in the nucleus accumbens inhibits cocaine-induced conditioned place preference
Brain Res.
(1995) - et al.
Blockade of `reverse tolerance' to cocaine and amphetamine by MK-801
Life Sci.
(1989) - et al.
The selective protein kinase C inhibitor, NPC 15437, induces specific deficits in memory retention in mice
Eur. J. Pharmacol.
(1992) - et al.
Drug addiction: a model for the molecular basis of neural plasticity
Neuron
(1993)
Biochemical correlates of long-term potentiation in hippocampal synapses
Int. Rev. Neurobiol.
Phosphorylation of amino acid neurotransmitter receptors in synaptic plasticity
Trends Neurosci.
The neural basis of drug-craving: an incentive-sensitization theory of addiction
Brain Res. Rev.
Cocaine increases extracellular levels of aspartate and glutamate in the nucleus accumbens
Brain Res.
Injection of the protein kinase inhibitor H7 into the A10 dopamine region blocks the acute responses to cocaine: behavioral and in vivo microdialysis studies
Neuropharmacology
Pretreatment with caerulein protects against memory impairment induced by protein kinase C inhibitors in the rat
Peptides
A general role for adaptations in G-proteins and the cyclic AMP system in mediating the chronic actions of morphine and cocaine on neuronal function
Brain Res.
Cocaine-induced expression of striatal c-fos in the rat is inhibited by NMDA receptor antagonists
Brain Res. Bull.
Context-specific cross-sensitization between systemic cocaine and intra-accumbens AMPA infusion in the rat
Psychopharmacology
A synaptic model of memory: long-term potentiation in the hippocampus
Nature
Differential effects of excitotoxic lesions of the amygdala on cocaine-induced conditioned locomotion and conditioned place preference
Psychopharmacology
Cited by (0)
- 1
Present address: School of Molecular and Medical Biosciences, University of Wales, Cardiff, Museum Avenue, P.O. Box 911, Cardiff CF1 3US, UK.